Skip to main content
Skip to content
Case File
sd-10-EFTA01382350Dept. of JusticeOther

EFTA Document EFTA01382350

Amendment No. 3 to Form S-1 Table of Contents Following this offering, we intend to utilize these exemptions. As a result, we will not have a majority of independent directors nor will our nominating and corporate governance and compensation committees consist entirely of independent directors. Accordingly, you will not have the same protections afforded to stockholders of companies that are subject to all of the NYSE corporate governance requirements. In the event that we cease to be a co

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01382350
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

Amendment No. 3 to Form S-1 Table of Contents Following this offering, we intend to utilize these exemptions. As a result, we will not have a majority of independent directors nor will our nominating and corporate governance and compensation committees consist entirely of independent directors. Accordingly, you will not have the same protections afforded to stockholders of companies that are subject to all of the NYSE corporate governance requirements. In the event that we cease to be a co

Ask AI About This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
Amendment No. 3 to Form S-1 Table of Contents Following this offering, we intend to utilize these exemptions. As a result, we will not have a majority of independent directors nor will our nominating and corporate governance and compensation committees consist entirely of independent directors. Accordingly, you will not have the same protections afforded to stockholders of companies that are subject to all of the NYSE corporate governance requirements. In the event that we cease to be a controlled company within the meaning of these rules, we will be required to comply with these provisions after specified transition periods. More specifically, if we cease to be a controlled company within the meaning of these rules, we will be required to (i) satisfy the majority independent board requirement within one year of our status change, and (ii) have (a) at least one independent member on each of our nominating and corporate governance committee and compensation committee by the date of our status change, (b) at least a majority of independent members on each committee within 90 days of the date of our status change and (c) fully independent committees within one year of the date of our status change. Board Leadership Structure Our board of directors does not have a formal policy on whether the roles of Chief Executive Officer and Chairman of the board of directors should be separate. However, Robert G. Miller currently serves as both Chief Executive Officer and Chairman. Our board of directors has considered its leadership structure and believes at this time that our company and its stockholders are best served by having one person serve in both positions. Combining the roles fosters accountability, effective decision-making and alignment between interests of our board of directors and management. Mr. Miller also is able to use the in-depth focus and perspective gained in his executive function to assist our board of directors in addressing both internal and external issues affecting the company. Our corporate governance guidelines provide for the election of one of our non-management directors to serve as Lead Director when the Chairman of the board of directors is also the Chief Executive Officer. Lenard B. Tessler currently serves as our Lead Director. and is responsible for serving as a liaison between the Chairman and the non-management directors, approving meeting agendas and schedules for our board and presiding at executive sessions of the non-management directors and any other board meetings at which the Chairman is not present, among other responsibilities. Our board of directors expects to periodically review its leadership structure to ensure that it continues to meet the company's needs. Role of Board in Risk Oversight While the full board of directors has the ultimate oversight responsibility for the risk management process, its committees oversee risk in certain specified areas. In particular, our audit and risk committee oversees management of enterprise risks as well as financial risks. Our compensation committee is responsible for overseeing the management of risks relating to our executive compensation plans and arrangements and the incentives created by the compensation awards it administers. Our compliance committee is responsible for overseeing the management of compliance and regulatory risks facing our company and risks associated with business conduct and ethics. Our nominating and corporate governance committee oversees risks associated with corporate governance. Pursuant to our board of directors' instruction, management regularly reports on applicable risks to the relevant committee or the full board of directors, as appropriate, with additional review or reporting on risks conducted as needed or as requested by our board of directors and its committees. 135 Mtn. WMV. See .11O% Archk edgar data' 1646972 000119312515335826'd900395ds Itt.htm110 14'2015 9:03:02 AM1 CONFIDENTIAL - PURSUANT TO FED. R. GRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0081674 SDNY_GM_00227858 EFTA01382350

Technical Artifacts (2)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Flight #AM1
Phone12515335826

Related Documents (6)

Dept. of JusticeMar 11, 2011

FBI Bruce E Ivins Investigation

010347Anthrax Page 1 of 1274 (Rev. 01-31-2003) FEDERAL BUREAU OF INVESTIGATION o Precedence: To: From: ROUTINE Date: 02/01/2007 Washington Field Washington Field Squad AMX-1/~VRA Contact: SAl ~--~~--------------------------~ b6 Approved By: Drafted By: Case ID #: 279A-WF-222936 ~79A-WF-222936-BEI (Pending) .. {{t;1%l.O (Pending)-1 279A-WF-222936-BEI-FISUR (Pending) -/ Title: AMERITHRAX; MAJOR CASE 184 ....?,-;-~"$'- Synopsis: Opening of sub-files for the'--'.:9a'ptioned matter. D

1274p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01441150

Deutsche Bank Private Wealth IVIanagement Corporate Account Authorization and Terms and Conditions Officer's Certificate Account Number: (\j LI /X/ V ^ ""Vi-"yh" • elected and acting pf 3- Epstein Virgin Islands Foundation, Inc (the "Corporation") hereby certify that: (1) The following resolutions were adopted by unanimous corvsent of the Board of Directors of the Corporation on the •Wi. RESOLVED, that any persons designated by the of the Corporation are auttwrized on behalf of th

41p
Dept. of JusticeAug 22, 2017

15 July 7 2016 - July 17 2016 working progress_Redacted.pdf

Kristen M. Simkins From: Sent: To: Cc: Subject: Irons, Janet < Tuesday, July 12, 2016 10:47 AM Richard C. Smith     Hello Warden Smith,     mother is anxious to hear the results of your inquiry into her daughter's health.   I'd be grateful if you could  email or call me at your earliest convenience.  I'm free today after 2 p.m.  Alternatively, we could meet after the Prison  Board of Inspectors Meeting this coming Thursday.    Best wishes,    Janet Irons    1 Kristen M. Simkins From: Sent:

1196p
Dept. of JusticeMay 26, 2015

Correctional Center RFP

Texas Department of Criminal Justice Brad Livingston Executive Director April 24, 2008 Re: Request for Proposals 696-PF-8-P030, Correctional Centers and/or Lockhart Work Program Facility Services Dear Prospective Offeror: Enclosed for your consideration is the above referenced solicitation for the operation and maintenance of Correctional Centers and/or Lockhart Work Program Facilities. When submitting proposals, please ensure all required information is included. Section of the soli

177p
Dept. of JusticeMar 11, 2011

FBI USAMRID Investigation

011621Anthrax Page 1 of 1446 o I 2792\-WF-222936-'-USAMRIID - \\OC o I [he followijg investigation was conducted by Special Agent (SA)_ _of the federal Bureau of Investigation (FBI) on February 24, 2005: ? The United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Keycard Access records from 1998 through 2002 were queried f r v' ? ? ? scientist nd visitin scient'st both ?rom the who have p eviously been identified as visiting USAMRIID circa May 1998. ;11 available

1446p
Dept. of JusticeAug 22, 2017

17 August 16 through August 31 2016_Redacted.pdf

Kristen M. Simkins From: Sent: To: Subject: Attachments: Juan Mendez Tuesday, August 16, 2016 1:10 AM Brenda A. McKinley; C. Kay Woodring; Caitlyn D. Neff; Danielle Minarchick; Eric A. Lockridge; Jeffrey T. Hite; Jonathan M. Millinder; Julie A. Simoni; Kevin T. Jeirles; Larry L. Lidgett; Lee R. Sheaffer; Lorinda L. Brown; Matthew T. Fisher; Melanie L. Gordon; Michael S. Woods; Richard C. Smith; Stephanie D. McGhee; Thomas S. Allen, Jr.; Walter E. Jeirles Calendar and Status Report 8/16/2016 20

1846p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.